Intestinal microbes provide multicellular hosts with nutrients and confer resistance to infection. The delicate balance between pro-and anti-inflammatory mechanisms, essential for gut immune homeostasis, is affected by the composition of the commensal microbial community. Regulatory T cells (T reg cells) expressing transcription factor Foxp3 have a key role in limiting inflammatory responses in the intestine 1 . Although specific members of the commensal microbial community have been found to potentiate the generation of antiinflammatory T reg or pro-inflammatory T helper 17 (T H 17) cells 2-6 , the molecular cues driving this process remain elusive. Considering the vital metabolic function afforded by commensal microorganisms, we reasoned that their metabolic by-products are sensed by cells of the immune system and affect the balance between pro-and antiinflammatory cells. We tested this hypothesis by exploring the effect of microbial metabolites on the generation of anti-inflammatory T reg cells. We found that in mice a short-chain fatty acid (SCFA), butyrate, produced by commensal microorganisms during starch fermentation, facilitated extrathymic generation of T reg cells. A boost in T reg -cell numbers after provision of butyrate was due to potentiation of extrathymic differentiation of T reg cells, as the observed phenomenon was dependent on intronic enhancer CNS1 (conserved non-coding sequence 1), essential for extrathymic but dispensable for thymic T reg -cell differentiation 1,7 . In addition to butyrate, de novo T reg -cell generation in the periphery was potentiated by propionate, another SCFA of microbial origin capable of histone deacetylase (HDAC) inhibition, but not acetate, which lacks this HDAC-inhibitory activity. Our results suggest that bacterial metabolites mediate communication between the commensal microbiota and the immune system, affecting the balance between pro-and anti-inflammatory mechanisms.
Intestinal microbes provide multicellular hosts with nutrients and confer resistance to infection. The delicate balance between pro-and anti-inflammatory mechanisms, essential for gut immune homeostasis, is affected by the composition of the commensal microbial community. Regulatory T cells (T reg cells) expressing transcription factor Foxp3 have a key role in limiting inflammatory responses in the intestine 1 . Although specific members of the commensal microbial community have been found to potentiate the generation of antiinflammatory T reg or pro-inflammatory T helper 17 (T H 17) cells [2] [3] [4] [5] [6] , the molecular cues driving this process remain elusive. Considering the vital metabolic function afforded by commensal microorganisms, we reasoned that their metabolic by-products are sensed by cells of the immune system and affect the balance between pro-and antiinflammatory cells. We tested this hypothesis by exploring the effect of microbial metabolites on the generation of anti-inflammatory T reg cells. We found that in mice a short-chain fatty acid (SCFA), butyrate, produced by commensal microorganisms during starch fermentation, facilitated extrathymic generation of T reg cells. A boost in T reg -cell numbers after provision of butyrate was due to potentiation of extrathymic differentiation of T reg cells, as the observed phenomenon was dependent on intronic enhancer CNS1 (conserved non-coding sequence 1), essential for extrathymic but dispensable for thymic T reg -cell differentiation 1, 7 . In addition to butyrate, de novo T reg -cell generation in the periphery was potentiated by propionate, another SCFA of microbial origin capable of histone deacetylase (HDAC) inhibition, but not acetate, which lacks this HDAC-inhibitory activity. Our results suggest that bacterial metabolites mediate communication between the commensal microbiota and the immune system, affecting the balance between pro-and anti-inflammatory mechanisms.
We explored potential mechanisms of induction of anti-inflammatory T reg cells by commensal microrganisms. We considered the possibility that microbial metabolites facilitate generation of extrathymic T reg cells, and if so, such products are likely to be found in the faeces of specific pathogen-free (SPF) mice with a normal spectrum of commensal microorganisms, but not in that of microbiota-deficient mice treated with broad-spectrum antibiotics (AVNM) or germ-free mice. Indeed, we found that polar solvent extracts of faeces from SPF, but not germ-free or AVNM-treated mice potentiated induction of Foxp3 after stimulation of purified peripheral naive (CD44 lo CD62L hi CD25 2 ) CD4 1 T cells by CD3 antibody in the presence of dendritic cells, interleukin-2 (IL-2), and transforming growth factor-b (TGF-b) ( Fig. 1a ). Among bacterial metabolites we expected to find short-chain fatty acids (SCFAs), and evaluated their content in faecal extracts from SPF, germ-free or AVNMtreated mice and their ability to affect T reg -cell generation. Analysis of hydrazine-derivatized SCFAs by high-performance liquid chromatography (HPLC) showed a sharp reduction in propionate and butyrate in extracts from germ-free and AVNM-treated versus SPF animals ( Fig. 1b ). Concentrations of these SCFAs in extracts were within a 5-mM range, corresponding to approximately 100-125 mM in in vitro Foxp3 induction assays (data not shown). Furthermore, purified butyrate, and to a lesser degree isovalerate and propionate, but not acetate, augmented TGF-b-dependent generation of Foxp3 1 cells in vitro ( Fig. 1c ; data not shown). To exclude the possibility that butyrate allowed for expansion of a few contaminating T reg cells in the starting naive CD4 1 T-cell population, we used mice lacking an intronic Foxp3 enhancer CNS1. These mice are selectively impaired in extrathymic T reg -cell differentiation but have intact thymic differentiation 1, 7 . Butyrate failed to rescue the impaired Foxp3 induction in naive CD4 1 T cells in the absence of CNS1 ( Fig. 1d Foxp3 expression was assessed by flow cytometric analysis on day 4 of culture. Naive CD25 2 CD62L hi CD44 lo CD4 1 T cells were FACS-purified from B6 mice. Faecal extracts were prepared in 70% ethanol. Data are shown as fold induction over corresponding dilution of vehicle and are representative of two independent experiments. b, HPLC fractionation of 2-nitrophenylhydrazine-HCl-derivatized SCFAs present in indicated faecal extracts. Red and yellow arrows indicate peaks corresponding to propionate (Prop) and butyrate (But), respectively. Asterisk, internal standard peak. The HPLC fractionation profile of faecal extracts pooled from three animals each is representative of two independent experiments. c, Effect of indicated purified SCFAs on in vitro induction of Foxp3 expression in naive CD4 1 T cells isolated from B6 or Foxp3 GFP mice as described in a. Data are representative of three independent experiments. d, Effect of butyrate on Foxp3 induction in CNS1-sufficient and -deficient naive CD4 1 T cells from Foxp3 GFP and Foxp3 DCNS1 mice as described in a. Data are representative of two or more independent experiments. diminish either qualitatively or quantitatively the TGF-b dependence of Foxp3 induction in CNS1-sufficient CD4 1 T cells (data not shown). These data suggest that butyrate promotes extrathymic differentiation of T reg cells.
To determine whether butyrate is capable of promoting extrathymic T reg -cell generation in vivo, we administered butyrate in drinking water to AVNM-treated mice, which exhibit a sharp decrease in microbially derived SCFAs, or untreated control SPF mice. Although we detected only very modest changes, if any, in the lymph node and splenic T reg -cell subsets in control mice, provision of butyrate to AVNM-treated animals resulted in a robust increase in peripheral, but not thymic or colonic T reg cells ( Fig. 2a, b and Supplementary  Fig. 1 ; data not shown). This increase was not an indirect consequence of an inflammatory response because non-lymphoid tissue histology and production of T H 1, T H 2, and T H 17 cytokines by Foxp3 2 CD4 1 T cells remained unchanged after butyrate treatment (data not shown; Supplementary Fig. 2 ). In agreement with the observed CNS1 dependence of in vitro Foxp3 induction, provision of butyrate to AVNMtreated CNS1-deficient mice did not increase the proportion or absolute numbers of T reg cells ( Fig. 2c ; data not shown). Thus, the observed butyrate-mediated increase in the T reg cell subset in vivo was due to increased extrathymic generation of T reg cells and not due to their increased thymic output 1, 7 . To ensure that butyrate reconstitution did not result in its non-physiologically high levels, we used liquid chromatography-mass spectrometry (LC-MS) to compare amounts of butyrate in the serum of AVNM-treated mice that received butyrate versus amounts found in control SPF mice. Although virtually undetectable in AVNM-treated CNS1-sufficient and -deficient animals, butyrate provision resulted in serum levels comparable to those found in unperturbed SPF mice that did not receive butyrate ( Fig. 2d ). Consistent with the aforementioned unchanged colonic T reg -cell subset in AVNM-treated mice that received butyrate in their drinking water, levels of butyrate in faecal pellets were not reconstituted in these mice, possibly owing to its uptake in the small intestine or stomach (data not shown). In contrast, delivery of butyrate by enema into the colon of CNS1-sufficient, but not CNS1-deficient mice, led to an increase in the T reg -cell subset in the colonic lamina propria ( Fig. 2e ). Thus, local provision of butyrate promoted CNS1-dependent extrathymic generation of T reg cells in the colon. Furthermore, feeding mice butyrylated starch, in the absence of antibiotic treatment, increased colonic T reg -cell subsets in comparison to a control starch diet (Supplementary Fig. 3 ) 8 . In addition to increasing T reg -cell numbers, restoration of butyrate levels in AVNM-treated animals did not decrease, but instead increased intracellular Foxp3 protein amounts on a per-cell basis in both CNS1-sufficient and -deficient mice, suggesting that this bacterial metabolite may also buttress pre-existing T reg -cell populations through stabilization of Foxp3 protein expression ( Fig. 2f ; data not shown).
In contrast to butyrate's ability to increase T reg -cell generation in the colon only after local, but not systemic delivery, other SCFAs, namely acetate and propionate, were recently shown to promote accumulation of T reg cells in the colon by activating GPR43 (ref. 9). These results suggest discrete modes of action of these three SCFAs. To test this idea we administered AVNM-treated CNS1-sufficient and -deficient mice with propionate and acetate in drinking water. Similarly to butyrate, oral provision of propionate increased T reg -cell subsets in the spleen in AVNM-treated CNS1-sufficient, but not -deficient animals, suggesting that propionate also promotes de novo generation of peripheral 
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T reg cells (Fig. 2g) . In contrast, acetate did not increase splenic T reg -cell numbers. These results were fully consistent with our in vitro T reg -cell differentiation studies (Fig. 1c ). However, in the colon, both acetate and propionate, but not butyrate, promoted accumulation of T reg cells in a CNS1-independent manner (Fig. 2g) . These results suggest that butyrate promotes de novo generation but not colonic accumulation of 
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T reg cells, whereas acetate has a diametrically opposite activity and propionate is capable of both. The observation that butyrate facilitates extrathymic differentiation of T reg cells raised a question as to whether butyrate directly affects T cells or dendritic cells (or both) by enhancing their ability to induce Foxp3 expression. To explore these non-mutually exclusive possibilities, we assessed the effects of butyrate on the ability of T cells and dendritic cells to generate T reg cells in vitro ( Fig. 3a-d) . We found that butyrate increased, albeit modestly (,1.5-fold), the numbers of Foxp3 1 cells in dendritic cell-free cultures of purified naive CD4 1 T cells stimulated by CD3 and CD28 antibody-coated beads and TGF-b (Fig. 3c ). Similar to T reg cells isolated from butyrate-treated mice, T reg cells generated in the presence of butyrate in vitro expressed not lower, but rather higher amounts of Foxp3 protein on a per-cell basis than those from butyrate-free cultures (Fig. 3d ). This effect was not associated with increased Foxp3 messenger RNA levels (Fig. 3e, f) . Instead, it is likely to be due to increased Foxp3 protein acetylation observed in the presence of butyrate, a known histone deacetylase (HDAC) inhibitor (Fig. 3g ). Foxp3 acetylation confers greater stability and enhanced function [10] [11] [12] [13] . Furthermore, the suppressor activity of T reg cells isolated from mice treated with AVNM and butyrate was not attenuated, but was moderately enhanced compared to mice treated with AVNM alone (Fig. 3h) .
Previous in vitro studies suggested that a synthetic HDAC inhibitor, trichostatin A (TSA), potentiates T reg -cell generation in vitro by acting on T cells 14, 15 . As butyrate can also boost extrathymic T reg -cell generation by acting directly on T cells in the absence of dendritic cells (Fig. 3c) , we assessed the effect of butyrate on histone modification at the Foxp3 locus. When naive CD4 1 T cells from Foxp3 GFP mice, which express a green fluorescent protein (GFP) reporter fused to Foxp3, were stimulated by CD3 and CD28 antibody-coated beads and TGF-b with or without butyrate for 3 days, a marked threefold increase in acetylated histone H3 at lysine 27 (acetylated H3K27) at the Foxp3 promoter and CNS1 enhancer was observed in Foxp3 2 cells purified from these cultures (Fig. 3i) . In contrast, increases in the acetylated H3K27 occupancy in their Foxp3 1 counterparts were expectedly minor (,30%) and inconsequential. Accordingly, Foxp3 mRNA levels were not different in Foxp3 1 cells in the presence or absence of butyrate (Fig. 3e, f) . Although we cannot discriminate between the contribution of increased acetylation of histone versus non-histone targets to heightened Foxp3 induction, it is likely to be facilitated by the increase in acetylated H3K27 observed in Foxp3 2 T cells.
In addition to its direct T reg -cell differentiation-promoting effects on CD4 1 T cell precursors, butyrate endowed dendritic cells with a superior ability to facilitate T reg -cell differentiation. Pre-treatment of dendritic cells with butyrate in vitro for 6 h followed by its removal markedly enhanced their ability to induce Foxp3 expression in naive CD4 1 T cells stimulated by CD3 antibody and TGF-b in the absence of butyrate ( Fig. 3a and Supplementary Fig. 4a, b ). This treatment had no detrimental effect on dendritic-cell viability ( Supplementary Fig. 4c ). The Foxp3 protein expression induced by butyrate-pre-treated and control dendritic cells was comparable, in contrast to a T-cell-intrinsic effect of butyrate leading to increased amounts of Foxp3 protein in T reg cells in mice treated with AVNM and butyrate (Figs 2f and 3b) .
We considered butyrate sensing by G-protein-coupled receptors (GPRs) as a potential mechanism for the increase in extrathymic differentiation of T reg cells 16, 17 . However, pre-treatment of Gpr109a 1/1 and Gpr109a 2/2 dendritic cells with butyrate similarly increased in vitro generation of Foxp3 1 cells ( Supplementary Fig. 5a ). Consistent with these results, butyrate-dependent potentiation of Foxp3 induction by dendritic cells remained unchanged after pre-treatment with pertussis toxin ( Supplementary Fig. 5b) 18 . Next, we tested HDAC inhibitory activity of butyrate and other SCFAs in dendritic cells using histone H3 acetylation as an indirect readout (Fig. 4a ). Trichostatin A (TSA) and valproate, two chemically distinct HDAC inhibitors, and phenylbutyrate, a butyrate derivative with a relatively weak inhibitory activity, were used as controls in these experiments. Relative HDAC inhibitory activity of SCFAs closely correlated with their ability to potentiate the capacity of dendritic cells to induce T reg -cell differentiation. Dendritic cells briefly exposed tobutyrate, TSA, and to a lesser extentpropionate, butnot acetate, potently induced Foxp3 expression ( Fig. 4b ). Furthermore, microarray analysis showed that butyrate and TSA induced remarkably similar, if not identical, gene-expression changes in dendritic cells (Supplementary Fig. 6a ) with a systemic repression of lipopolysaccharide (LPS) response genes including Il-12, Il-6 and Relb ( Supplementary Fig. 6b,  c) . Interestingly, repression of Relb, a major inducer of dendritic-cell activation, correlated with the level of HDAC-inhibitory activity of butyrate and other SCFAs (Fig. 4c) 19 . Notably, knockdown of Relb expression in dendritic cells promotes their ability to support T reg -cell differentiation 20, 21 . To further ascertain whether TSA and butyrate potentiated T reg -cell generation through HDAC inhibition and not through distinct independent mechanisms, we treated dendritic cells with the combination of butyrate and optimal amounts of TSA. If butyrate and TSA were to act through independent mechanisms, they should have exhibited synergistic effects on Foxp3 induction. However, if they acted on identical or related targets (that is, HDACs), additive effects were unlikely. We found that butyrate was unable to further enhance the ability of TSA to down-regulate Relb and promote Foxp3 induction ( Fig. 4d ; Supplementary Fig. 6d ), suggesting that they act on identical or related targets. These results are consistent with the idea that the HDAC inhibitory activity of butyrate as well as propionate contributes to the ability of dendritic cells to facilitate extrathymic T reg -cell differentiation.
In conclusion, our studies suggest that butyrate and propionate, produced by commensal microorganisms, increase extrathymic CNS1dependent differentiation of T reg cells. Our results indicate that metabolic inflammatory cytokine expression within dendritic cells to promote T reg induction. a, Histone acetylation in Flt3l-elicited dendritic cells from B6 mice treated with the indicated SCFA (500 mM) or TSA (10 nM) for 6 h followed by acid extraction of histones from isolated nuclei, SDS-PAGE and blotting with antibody for pan-acetylated H3 (pan H3). Total histone H3 served as a loading control. Shown is the relative acetylated H3 band intensity calculated over total H3 and normalized as fold over untreated. b, Induction of Foxp3 expression after stimulation of naive CD4 1 T cells by CD3 antibody in the presence of SCFA or TSA, Flt3l-elicited dendritic cells and TGF-b. Dendritic cells were cultured with titrated amounts SCFA or TSA for 6 h, washed and co-cultured with FACS-purified naive CD4 1 T cells in the presence of CD3 antibody and TGF-b. The data are shown as per cent CD4 1 cells expressing Foxp3 after 4 days of culture. Data are representative of two or more independent experiments. c, RelB gene expression quantified by qPCR in purified Flt3l-elicited dendritic cells from B6 mice treated for 6 h with SCFA or TSA, as in a. Data are representative of four independent experiments. d, RelB gene expression quantified by qPCR in purified Flt3l-elicited dendritic cells from B6 mice treated with or without TSA in combination with, or in the absence of, butyrate at the indicated concentrations. Data in this figure are representative of two or more independent experiments, unless otherwise noted. The data represent mean 6 s.e.m.
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by-products of commensal microorganisms influence the balance between pro-and anti-inflammatory cells and serve as a means of communication between the commensal microbial community and the immune system.
METHODS SUMMARY
CNS1 knockout (Foxp3 DCNS1 ), Foxp3 GFP , Foxp3 Thy1.1 and Foxp3 DTR mice have been described previously 7, 22, 23 . Male C57BL/6 mice were purchased from The Jackson Laboratory. All strains were maintained in the Sloan-Kettering Institute animal facility in accordance with institutional guidelines. For antibiotic treatment, mice were given 1 g l 21 metronidazole (Sigma-Aldrich), 0.5 g l 21 vancomycin (Hospira), 1 g l 21 ampicillin (Sigma-Aldrich) and 1 g l 21 kanamycin (Fisher Scientific) in drinking water (AVNM). For butyrate, acetate and propionate administration, each SCFA was added to AVNM-containing drinking water at 36 mM and pHadjusted as needed. Dendritic cells were expanded in vivo by subcutaneous injection of B16 melanoma cells secreting FLT3-ligand and purified using CD11c (N418) magnetic beads (Dynabeads, Invitrogen). In vitro Foxp3 induction assays were performed by incubating 5.5 3 10 4 naive CD44 lo CD62L hi CD25 2 CD4 1 T cells sorted by FACS, in 1 mg ml 21 of CD3 antibody in the presence of dendritic cells in 96-well flat-bottom plates for 4 days. Alternatively, naive CD4 1 T cells were stimulated with CD3 and CD28 antibody-coated beads (Dynabeads Mouse T-Activator, Invitrogen) at a 1:1 cell-to-bead ratio. All cultures were supplemented with 1 ng ml 21 TGF-b and 100 units ml 21 IL-2. Intracellular staining for IL-17, interferon-c (IFN-c), IL-4, IL-13 and Foxp3 was performed using the Foxp3 staining kit (eBiosciences). Cytokine staining was performed after re-stimulation of ex vivo isolated cells with 5 mg ml 21 CD3 antibody and 5 mg ml 21 CD28 antibody in the presence of Golgi-plug (BD Biosciences) for 5 h. Stool samples were collected directly into sterile tubes from live mice and snap-frozen before preparation of material for SCFA quantification by HPLC or LC-MS. HPLC analysis of 2-nitrophenylhydrazine HCl-derivatized SCFAs present in stool extracts was performed as described elsewhere 24 . Acetylated H3K27 chromatin immunoprecipitation (ChIP) quantitative polymerase chain reaction (qPCR) was performed as previously described 25 .
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